Meeting
2023 ASCO Annual Meeting
Single-cell RNA and T cell receptor (TCR) sequencing in patients with HPV-positive head and neck squamous cell carcinoma (HNSCC) after induction CTLA4 and PD-1 immune checkpoint blockade (ICB).
Authors
Xianli Jiang
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
Xianli Jiang , Nils-Petter Rudqvist , Shaoheng Liang , Shengbin Ye , Shan He , Qingnan Liang , Michael A. Curran , Bo Jiang , Jagannadha Sastry , Keiko Akagi , Michelle D. Williams , Jack Phan , Neil D. Gross , Meng Li , Ken Chen , Maura L. Gillison
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03799445
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6056)
DOI
10.1200/JCO.2023.41.16_suppl.6056
Abstract #
6056
Poster Bd #
48
Abstract Disclosures
Similar Posters
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy.
First Author: Tuba Nur Gide
Poster
2016 ASCO Annual Meeting
Novel T cell exhaustion marker to predict monotherapy PD-1 compared to combination CTLA-4 and PD-1 response in melanoma.
First Author: Kimberly Loo
Poster
2015 ASCO Annual Meeting
Comprehensive characterization of PDL-1 and CTLA-4 in gastric cancer.
First Author: Hans Anton Schloesser
Poster
2024 ASCO Annual Meeting
Phase 1 study of BA3071, an anti–CTLA-4 conditionally active biologic, in combination with nivolumab in advanced solid tumors.
First Author: Jacob Stephen Thomas